Press "Enter" to skip to content

Nektar, Bristol combo drug shows signs of tumor reduction in bladder cancer patients

Nektar Therapeutics said on Friday some patients with advanced bladder cancer treated with a combination of its experimental treatment and Bristol-Myers Squibb Co’s immunotherapy, Opdivo, showed signs of tumor reduction in an early-stage study.

Original source:

Also Read:   Sputnik eyes India rollout in March, hopes for emergency use nod soon